Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

Reports Q4 revenue $164.88M, consensus $158.71M. “We have created a next-generation rare disease company on a pathway to profitability with ...

When Columbus resident Jennifer Roberts’ family gets together for the holidays, they typically play a few games of bingo for ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. “Stronger liquidity will ensure our ...

Total Revenue of $560 million, exceeding guidanceCrysvita® revenue of $410 million and Dojolvi® revenue of $88 million2025 Financial ...

Charlotte Proud, 33, was diagnosed with Brittle Bone Disease - osteogenesis imperfecta - at just two years old, and has ...

Charlotte Proud, a Sunderland University apprentice born with Osteogenesis Imperfecta (Brittle Bone Disease), is determined ...

Truist Securities maintained a positive outlook on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), reiterating a Buy rating and a price target of $140. The firm's analyst highlighted the company's ...

“My favorite movie is The Big Lebowski, the Unbreakable Boy second and then Zack Snyder’s Justice League. If I ever had to meet any actor, it would be Christian Bale. My favorite comedy actor, The ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

" Jay & Pamela " will be officially premiered on Tuesday, March 4, 2025, at 10/9C. Viewers can tune into the network to see the series and experience the inspirational journey of the couple. For those ...